1 Min Read
* Says it commences additional trial of phase I clinical trial for spastic paralysis treatment plasters(MRX-4TZT) in U.S.
Source text in Japanese: goo.gl/kJWhKv
Further company coverage: (Beijing Headline News)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.